HexArmor Helix® 3007 Schnittschutzhandschuh

HexArmor Helix® 3007 Schnittschutzhandschuh

Marsoni

M251S

$39.55

Get it in 3 business days with 1 day shipping. Friday, May 29

HexArmor Helix® 3007 SchnittschutzhandschuhHexArmor Helix Serie 3007: nahtlos beschichteter Schutzhandschuh fr Rettungseinstze Helix Serie 3007 von HexArmor ist ein nahtloser Handschuh mit branchenfhrendem Stoschutz an allen Fingern fr ausgezeichnetes Tastgefhl bei der Arbeit. Allgemeine Merkmale Ausgezeichnetes Tastgefhl bei Schnittschutzstufe D IR X Impact Exoskeleton Stoschutz im High Flex Design auf dem Handrcken Hohe Strapazierfhigkeit fr langanhaltenden Schutz Ultimative Beweglichkeit

Easy Shipping

Quick Dispatch:

Your HexArmor Helix® 3007 Schnittschutzhandschuh orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your HexArmor Helix® 3007 Schnittschutzhandschuh ships.

Need Help?
Questions about HexArmor Helix® 3007 Schnittschutzhandschuh, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for HexArmor Helix® 3007 Schnittschutzhandschuh in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

Good product, not much to say. The product arrived quickly, looks to be of high quality construction, fit perfectly and took me only a couple of minutes to install. I love it when a product is no frills and delivers as advertised. I've used various filters from K&N before and have always had very good success with them so I will be buying more of these for sure when the time comes.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on November 9, 2025